In agreement with our data, it has been shown that p53 can inhibit HIF1 activity by targeting the HIF1a subunit for Mdm2-mediated ubiquitination and proteasomal degradation, and that loss of p53 enhances hypoxia-induced HIF1a levels in tumor cells [51]. Here, MDM2 is linked to neoplasm.